ERBB2 and breast cancer: Here, we show that shRNA-mediated knockdown of FAM83A results in decreased PI3K/Akt signaling, inhibited two-dimensional and three-dimensional cell growth, and induced apoptosis in a panel of HER2+ BC cell lines, regardless of trastuzumab sensitivity.